HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Heparan Sulfate Mimetic PG545 Modulates T Cell Responses and Prevents Delayed-Type Hypersensitivity.

Abstract
The heparan sulfate mimetic PG545 (pixatimod) is under evaluation as an inhibitor of angiogenesis and metastasis including in human clinical trials. We have examined the effects of PG545 on lymphocyte phenotypes and function. We report that PG545 treatment suppresses effector T cell activation and polarizes T cells away from Th17 and Th1 and toward Foxp3+ regulatory T cell subsets in vitro and in vivo. Mechanistically, PG545 inhibits Erk1/2 signaling, a pathway known to affect both T cell activation and subset polarization. Interestingly, these effects are also observed in heparanase-deficient T cells, indicating that PG545 has effects that are independent of its role in heparanase inhibition. Consistent with these findings, administration of PG545 in a Th1/Th17-dependent mouse model of a delayed-type hypersensitivity led to reduced footpad inflammation, reduced Th17 memory cells, and an increase in FoxP3+ Treg proliferation. PG545 also promoted Foxp3+ Treg induction by human T cells. Finally, we examined the effects of other heparan sulfate mimetics PI-88 and PG562 on lymphocyte polarization and found that these likewise induced Foxp3+ Treg in vitro but did not reduce Th17 numbers or improve delayed-type hypersensitivity in this model. Together, these data indicate that PG545 is a potent inhibitor of Th1/Th17 effector functions and inducer of FoxP3+ Treg. These findings may inform the adaptation of PG545 for clinical applications including in inflammatory pathologies associated with type IV hypersensitivity responses.
AuthorsIevgen O Koliesnik, Hedwich F Kuipers, Carlos O Medina, Svenja Zihsler, Dan Liu, Jonas D Van Belleghem, Paul L Bollyky
JournalFrontiers in immunology (Front Immunol) Vol. 11 Pg. 132 ( 2020) ISSN: 1664-3224 [Electronic] Switzerland
PMID32117279 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2020 Koliesnik, Kuipers, Medina, Zihsler, Liu, Van Belleghem and Bollyky.
Chemical References
  • Angiogenesis Inhibitors
  • Forkhead Transcription Factors
  • Foxp3 protein, mouse
  • Oligosaccharides
  • PG 545
  • Saponins
  • phosphomannopentaose sulfate
  • Heparitin Sulfate
Topics
  • Angiogenesis Inhibitors (pharmacology)
  • Animals
  • Bone Marrow Cells
  • Dendritic Cells (drug effects)
  • Forkhead Transcription Factors (metabolism)
  • Heparitin Sulfate
  • Humans
  • Hypersensitivity
  • Lymphocyte Activation (drug effects)
  • Lymphocytes (drug effects)
  • MAP Kinase Signaling System (drug effects)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Oligosaccharides (pharmacology)
  • Primary Cell Culture
  • Saponins (pharmacology)
  • T-Lymphocytes (drug effects)
  • T-Lymphocytes, Regulatory (drug effects)
  • Th17 Cells (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: